This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Müller, H. L. Articles by Ozono, K. Search for Related Content PubMed PubMed Citation Articles by Müller, H. L. Articles by Ozono, K.

Asp³⁶¹Val Mutant of Alkaline Phosphatase Found in Patients with Dominantly Inherited Hypophosphatasia Inhibits the Activity of the Wild-Type Enzyme

Departments of Pediatrics (H.L.M.) and Nuclear Medicine (P.S.), University Hospital, D-97080 Würzburg; and the Department of Pediatrics, University Hospital (E.S.), 50924 Köln, Germany; and the Department of Environmental Medicine, Osaka Medical Center and Institute for Maternal and Child Health (M.Y., T.M., T.K., K.O.), Izumi, Osaka 594-1101, Japan

Address all correspondence and requests for reprints to: Keiichi Ozono, M.D., Department of Environmental Medicine, Osaka Medical Center and Institute for Maternal and Child Health, 840 Murodo-cho, Izumi, Osaka 594-1101, Japan.

Hypophosphatasia is characterized by the hypomineralization of bone associated with the mutation of the tissue-nonspecific alkaline phosphatase (TNSALP) gene. Although the disease is usually autosomal recessive, an autosomal dominant form is also recognized. Approximately 50 mutations have been found in the TNSALP gene in patients with hypophosphatasia. However, the mutations identified to date do not seem to account for the dominantly inherited form of the disease. We have examined a German family in which the father and all 4 children were affected with hypophosphatasia, whereas the mother was healthy. The affected members of this family showed premature loss of deciduous teeth at or shortly before 2 yr of age and low levels of serum ALP with elevated levels of urinary phosphoethanolamine. DNA analysis by direct sequencing revealed a heterozygous missense mutation that caused the conversion of amino acid Asp to Val at position 361 (D361V) in the patients. Another substitution was detected in exon 12 (Val to Ala conversion at codon 505: V505A) in 1 allele of the mother and 3 children, indicating no association of the substitution with the disease. Reconstruction experiments demonstrated that the D361V mutant protein lost its enzymatic activity and that it inhibited the function of wild-type enzyme when coexpressed in COS-7 cells. On the other hand, the V505A mutant exhibited enzymatic activities equal to those of the wild-type ALP. It is likely that the mutant D361V protein forms dimers with the wild-type protein, and the protein-protein interaction contributes to the dominant effect of the mutant D361V. The mutation that causes D361V is the first one proven to be associated with the dominant form of hypophosphatasia.

This article has been cited by other articles:

				M. P. Whyte, S. Mumm, and C. Deal Adult Hypophosphatasia Treated with Teriparatide J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1203 - 1208. [Abstract] [Full Text] [PDF]

				M Herasse, M Spentchian, A Taillandier, K Keppler-Noreuil, A N M Fliorito, J Bergoffen, R Wallerstein, C Muti, B Simon-Bouy, and E Mornet Molecular study of three cases of odontohypophosphatasia resulting from heterozygosity for mutations in the tissue non-specific alkaline phosphatase gene J. Med. Genet., August 1, 2003; 40(8): 605 - 609. [Full Text] [PDF]